Literature DB >> 9267973

Cognitive functions in major depression and Parkinson disease.

G Kuzis1, L Sabe, C Tiberti, R Leiguarda, S E Starkstein.   

Abstract

OBJECTIVE: To investigate the importance of major depression in the production of cognitive deficits in patients with Parkinson disease (PD).
DESIGN: A comprehensive neuropsychological and psychiatric assessment was conducted in 19 patients with PD and major depression, 31 patients with PD without depression, 27 patients with major depression but without PD, and 12 age-comparable healthy controls.
SETTING: Outpatient clinic.
RESULTS: Patients with major depression (with or without PD) had significantly more severe cognitive deficits than both healthy controls and patients with PD without depression on tests of verbal fluency and auditory attention, while patients with PD and major depression had significantly more severe deficits on tasks of abstract reasoning and set alternation compared with the other 3 groups.
CONCLUSIONS: Major depression in patients with PD is associated with significant deficits on specific cognitive tasks. While some of these deficits may be explained by the presence of major depression, frontal lobe-related cognitive impairments may result from an interaction between neuropathologic factors in PD and the mechanism of major depression.

Entities:  

Mesh:

Year:  1997        PMID: 9267973     DOI: 10.1001/archneur.1997.00550200046009

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  27 in total

1.  Escitalopram for major depression in Parkinson's disease: an open-label, flexible-dosage study.

Authors:  Daniel Weintraub; Donna Taraborelli; Knashawn H Morales; John E Duda; Ira R Katz; Matthew B Stern
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2006       Impact factor: 2.198

2.  Relationship between depression and cognitive dysfunctions in Parkinson's disease without dementia.

Authors:  Gabriella Santangelo; Carmine Vitale; Luigi Trojano; Katia Longo; Autilia Cozzolino; Dario Grossi; Paolo Barone
Journal:  J Neurol       Date:  2009-04-15       Impact factor: 4.849

3.  Dopaminergic modulation of memory and affective processing in Parkinson depression.

Authors:  Lee X Blonder; John T Slevin; Richard J Kryscio; Catherine A Martin; Anders H Andersen; Charles D Smith; Frederick A Schmitt
Journal:  Psychiatry Res       Date:  2013-07-06       Impact factor: 3.222

4.  Neuropsychological outcomes after psychosocial intervention for depression in Parkinson's disease.

Authors:  Roseanne D Dobkin; Alexander I Tröster; Jade Tiu Rubino; Lesley A Allen; Michael A Gara; Margery H Mark; Matthew Menza
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2014       Impact factor: 2.198

Review 5.  Depression in Parkinson's disease. Pharmacological characteristics and treatment.

Authors:  T Tom; J L Cummings
Journal:  Drugs Aging       Date:  1998-01       Impact factor: 3.923

Review 6.  Neuropsychiatric aspects of Parkinson's disease: recent advances.

Authors:  Laura Marsh; Ariel Berk
Journal:  Curr Psychiatry Rep       Date:  2003-05       Impact factor: 5.285

7.  Chronic escitalopram treatment restores spatial learning, monoamine levels, and hippocampal long-term potentiation in an animal model of depression.

Authors:  V Bhagya; B N Srikumar; T R Raju; B S Shankaranarayana Rao
Journal:  Psychopharmacology (Berl)       Date:  2010-11-04       Impact factor: 4.530

Review 8.  Interaction Between Neuropsychiatric Symptoms and Cognitive Performance in Parkinson's Disease: What Do Clinical and Neuroimaging Studies Tell Us?

Authors:  Alexandru Hanganu; Oury Monchi
Journal:  Curr Neurol Neurosci Rep       Date:  2018-10-15       Impact factor: 5.081

9.  The impact of antidepressant treatment on cognitive functioning in depressed patients with Parkinson's disease.

Authors:  Roseanne DeFronzo Dobkin; Matthew Menza; Karina L Bienfait; Michael Gara; Humberto Marin; Margery H Mark; Allison Dicke; Alexander Tröster
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2010       Impact factor: 2.198

Review 10.  Role of dopamine in learning and memory: implications for the treatment of cognitive dysfunction in patients with Parkinson's disease.

Authors:  J Kulisevsky
Journal:  Drugs Aging       Date:  2000-05       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.